immunocore-logo-2018
Immunocore to present at upcoming investor conferences
08 nov. 2024 07h00 HE | Immunocore Holdings plc
(OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & GAITHERSBURG, Md., US, 8 November 2024) Immunocore Holdings plc (Nasdaq: IMCR) (“Immunocore” or the “Company”), a commercial-stage biotechnology...
GENELUX-Final-Logo-Notagline.png
Genelux Corporation to Participate in Fireside Chat at the Guggenheim Inaugural Healthcare Innovation Conference
06 nov. 2024 16h01 HE | Genelux Corporation
WESTLAKE VILLAGE, Calif., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced that Thomas Zindrick, President, CEO...
barinthuslogo.jpg
Barinthus Bio Announces Late Breaking Presentation at AASLD 2024 – The Liver Meeting® and Attendance at November Conferences
31 oct. 2024 08h00 HE | Barinthus Biotherapeutics
Barinthus Bio Announces Late Breaking Presentation at AASLD 2024 – The Liver Meeting® and Attendance at November Conferences
Inflarx logo.png
InflaRx to Report Third Quarter 2024 Financial Results on November 8 and to Participate in Guggenheim Inaugural Healthcare Innovation Conference
31 oct. 2024 07h30 HE | InflaRx N.V.
JENA, Germany, Oct. 31, 2024 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today...
Immuneering-logo (1).png
Immuneering Announces Participation in February Investor Conferences
01 févr. 2024 08h00 HE | Immuneering Corporation
CAMBRIDGE, Mass., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company seeking to develop universal-RAS/RAF medicines for broad populations of...
Icosavax_Logo.jpg
Icosavax to Participate in the Guggenheim Healthcare Talks 5th Annual Inflammation, Neurology & Immunology (INI) Conference
31 oct. 2023 08h00 HE | Icosavax, Inc.
SEATTLE, Oct. 31, 2023 (GLOBE NEWSWIRE) -- Icosavax, Inc. (Nasdaq: ICVX), a biopharmaceutical company leveraging its innovative virus-like particle (VLP) platform technology to develop vaccines...
Onconova Logo BLUE.jpg
Onconova Therapeutics to Present at the 2023 Guggenheim Oncology Conference
01 févr. 2023 08h00 HE | Onconova Therapeutics, Inc.
NEWTOWN, Pa., Feb. 01, 2023 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), (“Onconova”), a clinical-stage biopharmaceutical company focused on discovering and developing novel...
01_PrimaryLogo_Color_BlueX-100.jpg
Praxis Precision Medicines to Present at Guggenheim Nantucket Therapeutics Conference
21 sept. 2022 09h00 HE | Praxis Precision Medicines, Inc.
BOSTON, Sept. 21, 2022 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies...
VIR_logo_large.jpg
Vir Biotechnology to Participate in the Guggenheim 2nd Annual Vaccine & Infectious Disease Day Conference
30 sept. 2021 16h05 HE | Vir Biotechnology, Inc.
SAN FRANCISCO, Sept. 30, 2021 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that Phil Pang, M.D., Ph.D., chief medical officer, is scheduled to present at the Guggenheim...
Celebration 2019_Alan Schwartz
Youth INC Celebrates 25 Years of Impact Raising Over $3M for New York City Kids
14 nov. 2019 14h30 HE | Youth INC
NEW YORK, Nov. 14, 2019 (GLOBE NEWSWIRE) -- Youth INC held its 25th Annual Celebration Gala at the Grand Hyatt New York last night. The event raised over $2.1 million to directly support Youth INC’s...